Literature DB >> 19437551

Mitochondrial dysfunction in a neural cell model of spinal muscular atrophy.

Gyula Acsadi1, Icksoo Lee, Xingli Li, Magomed Khaidakov, Alena Pecinova, Graham C Parker, Maik Hüttemann.   

Abstract

Mutations of the survival motor neuron (SMN) gene in spinal muscular atrophy (SMA) lead to anterior horn cell death. The cause is unknown, but motor neurons depend substantially on mitochondrial oxidative phosphorylation (OxPhos) for normal function. Therefore, mitochondrial parameters were analyzed in an SMA cell culture model using small interfering RNA (siRNA) transfection that decreased Smn expression in NSC-34 cells to disease levels. Smn siRNA knock-down resulted in 35% and 66% reduced Smn protein levels 48 and 72 hr posttransfection, respectively. ATP levels were reduced by 14% and 26% at 48 and 72 hr posttransfection, respectively, suggesting decreased ATP production or increased energy demand in neural cells. Smn knock-down resulted in increased mitochondrial membrane potential and increased free radical production. Changes in activity of cytochrome c oxidase (CcO), a key OxPhos component, were observed at 72 hr with a 26% increase in oxygen consumption. This suggests a compensatory activation of the aerobic pathway, resulting in increased mitochondrial membrane potentials, a condition known to lead to the observed increase in free radical production. Further testing suggested that changes in ATP at 24 hr precede observable indices of cell injury at 48 hr. We propose that energy paucity and increased mitochondrial free radical production lead to accumulated cell damage and eventual cell death in Smn-depleted neural cells. Mitochondrial dysfunction may therefore be important in SMA pathology and may represent a new therapeutic target.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19437551     DOI: 10.1002/jnr.22106

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  44 in total

1.  SOD1 targeted to the mitochondrial intermembrane space prevents motor neuropathy in the Sod1 knockout mouse.

Authors:  Lindsey R Fischer; Anissa Igoudjil; Jordi Magrané; Yingjie Li; Jason M Hansen; Giovanni Manfredi; Jonathan D Glass
Journal:  Brain       Date:  2010-11-14       Impact factor: 13.501

2.  Alpha-synuclein loss in spinal muscular atrophy.

Authors:  Gyula Acsadi; Xingli Li; Kelley J Murphy; Kathryn J Swoboda; Graham C Parker
Journal:  J Mol Neurosci       Date:  2010-07-17       Impact factor: 3.444

3.  miR-206 Reduces the Severity of Motor Neuron Degeneration in the Facial Nuclei of the Brainstem in a Mouse Model of SMA.

Authors:  Valeria Valsecchi; Serenella Anzilotti; Angelo Serani; Giusy Laudati; Paola Brancaccio; Natascia Guida; Ornella Cuomo; Giuseppe Pignataro; Lucio Annunziato
Journal:  Mol Ther       Date:  2020-01-15       Impact factor: 11.454

Review 4.  Advances in therapy for spinal muscular atrophy: promises and challenges.

Authors:  Ewout J N Groen; Kevin Talbot; Thomas H Gillingwater
Journal:  Nat Rev Neurol       Date:  2018-02-09       Impact factor: 42.937

5.  Proteomic profile of embryonic stem cells with low survival motor neuron protein is consistent with developmental dysfunction.

Authors:  Graham C Parker; Nicholas J Carruthers; Theresa Gratsch; Joseph A Caruso; Paul M Stemmer
Journal:  J Neural Transm (Vienna)       Date:  2016-05-05       Impact factor: 3.575

6.  Motor neuron mitochondrial dysfunction in spinal muscular atrophy.

Authors:  Nimrod Miller; Han Shi; Aaron S Zelikovich; Yong-Chao Ma
Journal:  Hum Mol Genet       Date:  2016-08-03       Impact factor: 6.150

7.  Identification of a Maleimide-Based Glycogen Synthase Kinase-3 (GSK-3) Inhibitor, BIP-135, that Prolongs the Median Survival Time of Δ7 SMA KO Mouse Model of Spinal Muscular Atrophy.

Authors:  Po C Chen; Irina N Gaisina; Bassem F El-Khodor; Sylvie Ramboz; Nina R Makhortova; Lee L Rubin; Alan P Kozikowski
Journal:  ACS Chem Neurosci       Date:  2012-01-18       Impact factor: 4.418

8.  Altered intracellular Ca2+ homeostasis in nerve terminals of severe spinal muscular atrophy mice.

Authors:  Rocío Ruiz; Juan José Casañas; Laura Torres-Benito; Raquel Cano; Lucía Tabares
Journal:  J Neurosci       Date:  2010-01-20       Impact factor: 6.167

9.  A suggested role for mitochondria in Noonan syndrome.

Authors:  Icksoo Lee; Alena Pecinova; Petr Pecina; Benjamin G Neel; Toshiyuki Araki; Raju Kucherlapati; Amy E Roberts; Maik Hüttemann
Journal:  Biochim Biophys Acta       Date:  2009-10-14

Review 10.  SMN regulation in SMA and in response to stress: new paradigms and therapeutic possibilities.

Authors:  Catherine E Dominguez; David Cunningham; Dawn S Chandler
Journal:  Hum Genet       Date:  2017-08-29       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.